Ollin Biosciences has announced positive topline results from its randomized, head-to-head Phase 1b JADE clinical study ...
Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...
Individuals who are Black or Hispanic are at greater risk of long-term adverse visual outcomes of diabetic retinopathy compared with other groups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback